Researchers call for alteplase rethink

The anti-clotting drug alteplase should be used no more than three hours after an acute ischaemic stroke, say researchers.

Current guidelines support its use in thrombolysis for up to 4.5 hours, but Dr Brian Alper and colleagues have found inconsistencies in the data.